申请人:Altenbach Robert J.
公开号:US20090054420A1
公开(公告)日:2009-02-26
Compounds of formula (I)
are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
公式(I)的化合物可用于治疗由组胺-3受体配体预防或改善的情况或疾病。还公开了包含组胺-3受体配体的药物组合物,使用这些化合物和组合物的方法,以及制备公式(I)范围内化合物的过程。